Get the Stockscreener App
65.97
0.21%
-0.14
Pre-market:
66.11
0.14
+0.21%
Prestige Consumer Healthcare Inc stock is traded at $65.97, with a volume of 348.44K.
It is down -0.21% in the last 24 hours and up +2.81% over the past month.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
See More
Previous Close:
$66.11
Open:
$66.01
24h Volume:
348.44K
Relative Volume:
0.83
Market Cap:
$3.12B
Revenue:
$1.11B
Net Income/Loss:
$200.84M
P/E Ratio:
16.36
EPS:
4.0314
Net Cash Flow:
$255.45M
1W Performance:
-1.58%
1M Performance:
+2.81%
6M Performance:
+3.26%
1Y Performance:
-23.26%
1-Day Range:
$64.97
$66.81
1-Week Range:
$63.69
$68.62
52-Week Range:
$57.25
$90.04
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Name
Prestige Consumer Healthcare Inc
Sector
Phone
(914) 524-6800
Address
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
65.97 | 3.13B | 1.11B | 200.84M | 255.45M | 4.0314 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Upgrade | Sidoti | Neutral → Buy |
| Dec-09-24 | Downgrade | Sidoti | Buy → Neutral |
| Jun-21-24 | Upgrade | DA Davidson | Neutral → Buy |
| Nov-17-22 | Initiated | Canaccord Genuity | Buy |
| May-10-22 | Upgrade | Jefferies | Hold → Buy |
| May-09-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-07-20 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-29-20 | Upgrade | Sidoti | Neutral → Buy |
| Apr-14-20 | Downgrade | Jefferies | Buy → Hold |
| Apr-07-20 | Resumed | Sidoti | Neutral |
| Mar-26-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-24-20 | Initiated | Oppenheimer | Perform |
| Mar-19-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-04-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jun-02-17 | Upgrade | Jefferies | Underperform → Hold |
| May-22-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-27-16 | Reiterated | B. Riley & Co. | Buy |
| Nov-17-16 | Initiated | Gabelli & Co | Buy |
| Aug-12-16 | Upgrade | Sidoti | Neutral → Buy |
| Mar-08-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Feb-05-16 | Initiated | Piper Jaffray | Overweight |
| Nov-30-15 | Downgrade | Jefferies | Hold → Underperform |
| Apr-28-14 | Reiterated | B. Riley & Co. | Buy |
| Apr-28-14 | Reiterated | Oppenheimer | Outperform |
| Jul-09-13 | Initiated | B. Riley & Co. | Buy |
View All
Prestige Consumer Healthcare Inc Stock (PBH) Latest News
PBH's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Up - Zacks Investment Research
Fundamentals Check: What is Prestige Consumer Healthcare Incs 5 year growth outlookJobs Report & Real-Time Volume Analysis - baoquankhu1.vn
How Prestige Consumer Healthcare Inc. stock reacts to oil prices2025 Major Catalysts & Advanced Swing Trade Entry Plans - mfd.ru
Prestige Consumer Healthcare Inc. Just Missed EarningsBut Analysts Have Updated Their Models - 富途牛牛
Prestige Consumer Healthcare narrows fiscal 2026 revenue outlook to $1.1B while advancing Clear Eyes supply recovery - MSN
Prestige Consumer Healthcare (PBH) Valuation Check After Clear Eyes Supply Headwinds And Pillar5 Acquisition - Yahoo Finance
Prestige Consumer Healthcare Inc. $PBH Stock Position Decreased by Bessemer Group Inc. - MarketBeat
Prestige Consumer Healthcare Q3 Earnings Call Highlights - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Prestige Consumer Healthcare (PBH), McKesson (MCK) and Bristol-Myers Squibb (BMY) - The Globe and Mail
Prestige Deal For Stampede Culinary Partners Reshapes Earnings And Valuation Potential - Sahm
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q3 2026 Earnings Call Transcript - Insider Monkey
Prestige Consumer Healthcare Q3 FY26 slides: Strong cash flow offsets revenue decline By Investing.com - Investing.com South Africa
Decoding Prestige Consumer Healthcare Inc (PBH): A Strategic SWO - GuruFocus
Prestige Consumer Healthcare Q3 FY26 slides: Strong cash flow offsets revenue decline - Investing.com Nigeria
Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot - theheraldreview.com
Prestige Consumer Healthcare Q3 2026 Earnings Call Transcript - MarketBeat
Prestige Consumer Healthcare Inc (PBH) Q3 2026 Earnings Call Highlights: Navigating Challenges ... By GuruFocus - Investing.com Canada
Prestige Consumer Healthcare (NYSE:PBH) Releases Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Prestige Looks Well Positioned for Durable Growth as Clear Eyes Issue Gradually Recovers - Morningstar
Earnings call transcript: Prestige Consumer Healthcare reports steady Q3 2026 results - Investing.com India
Prestige Consumer Healthcare (PBH) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
PBH Adjusts FY26 Revenue Growth Expectations - GuruFocus
Prestige Consumer Healthcare Seeks M&A - marketscreener.com
Prestige Consumer Healthcare (NYSE:PBH) Issues FY 2026 Earnings Guidance - MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) Reports Mixed Q3 FY2026 Results, Misses Analyst Estimates - Chartmill
Prestige Consumer Healthcare Q3 Earnings Miss Expectations - Intellectia AI
Prestige Consumer Healthcare (PBH) Q3 Earnings Lag Estimates - Yahoo Finance
Prestige Consumer Fiscal Q3 Adjusted Earnings, Revenue Fall; Full-Year Outlook Revised - marketscreener.com
Prestige Consumer Healthcare Q3 revenue tops estimates, narrows guidance By Investing.com - Investing.com South Africa
Prestige Consumer Healthcare Q3 revenue tops estimates, narrows guidance - Investing.com
Prestige Consumer Healthcare Reports Q3 Results, Narrows Outlook - TipRanks
Earnings Flash (PBH) Prestige Consumer Healthcare Inc. Posts Q3 Adjusted EPS $1.14 per Share, vs. FactSet Est of $1.14 - marketscreener.com
Prestige Consumer Healthcare: Fiscal Third Quarter Earnings Overview - Bitget
Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results - The Manila Times
Prestige Consumer Healthcare Inc. SEC 10-Q Report - TradingView
Insights into Prestige Consumer Q3 Earnings - Benzinga
Prestige Consumer Health earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
Prestige Consumer's Earnings: A Preview - Benzinga
Aug Spikes: Why is Prestige Consumer Healthcare Inc stock going upJuly 2025 Update & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Price-Driven Insight from (PBH) for Rule-Based Strategy - Stock Traders Daily
Prestige Consumer Healthcare (PBH) Stock Analysis: Strong Buy Ratings Signal Nearly 20% Upside Potential - DirectorsTalk Interviews
Prestige Consumer Healthcare Inc. (PBH): A bull case theory - MSN
Prestige Consumer Healthcare Inc. (PBH): A Bull Case Theory - Finviz
Jefferies Maintains "Hold" Rating on Prestige Consumer (PBH), Lo - GuruFocus
Jefferies Maintains Hold on Prestige Consumer Healthcare Inc. (PBH) Jan 30 2026 - Meyka
Retail Trends: Why is Prestige Consumer Healthcare Inc stock going up2025 Key Highlights & High Conviction Trade Alerts - baoquankhu1.vn
Great Lakes Advisors LLC Has $4.96 Million Stake in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Y Intercept Hong Kong Ltd Has $2.04 Million Stock Position in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare (PBH) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Market Trends: Is Eureka Acquisition Corp Debt Equity Composite Units on track to beat earningsPortfolio Value Summary & High Conviction Buy Zone Alerts - baoquankhu1.vn
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring an 18.54% Upside Potential - DirectorsTalk Interviews
Prestige Consumer Healthcare Inc Stock (PBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.21%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):